Kinnate Biopharma Inc.
Inhibitors of RAF kinases

Last updated:

Abstract:

Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.

Status:
Grant
Type:

Utility

Filling date:

11 Oct 2021

Issue date:

5 Jul 2022